BIOMAT Database Logo BIOMAT Database Logo

Severe interactions with classic and selective monoamine oxidase inhibitors. 1998

C L Errando, and E Mateo, and D López-Alarcón, and S Moliner

UI MeSH Term Description Entries
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000758 Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.

Related Publications

C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Letter: Interactions with monoamine oxidase inhibitors.
September 1975, British medical journal,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Letter: Interactions with monoamine oxidase inhibitors.
October 1975, British medical journal,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
[Monoamine oxidase inhibitors: poisoning and interactions].
September 1993, Nederlands tijdschrift voor geneeskunde,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Requiem or resurrection: Classic monoamine oxidase inhibitors revisited.
August 2022, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Interactions of monoamine oxidase with substrates and inhibitors.
January 1989, Medicinal research reviews,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
October 1996, Clinical neuropharmacology,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
[Irreversible, non-selective monoamine oxidase inhibitors].
April 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Monoamine oxidase: multiple forms and selective inhibitors.
February 1971, The Biochemical journal,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Drug interactions with reversible monoamine oxidase-A inhibitors.
January 1993, Clinical neuropharmacology,
C L Errando, and E Mateo, and D López-Alarcón, and S Moliner
Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors.
January 2022, Health psychology research,
Copied contents to your clipboard!